Prostate cancer: A growing health concern for Caribbean men
Key Points(5)
- As September marks Prostate Cancer Awareness Month, attention is being drawn to a disease that continues to affect men across the Caribbean.
- Beyond the statistics, prostate cancer presents a growing challenge for families, healthcare providers and a region already grappling with the burden of noncommunicable diseases.
- Prostate cancer is the most frequently diagnosed cancer among Caribbean men and a leading cause of cancer-related deaths.
- A Caribbean concern Research published in 2022 on prostate cancer in the Caribbean reported an age-standardized incidence rate of approximately 76 cases per 100,000 men and a mortality rate of 28 deaths per 100,000 men in 2020.
- These figures demonstrate the seriousness of the disease across the region, although rates vary among individual countries and territories.
As September marks Prostate Cancer Awareness Month, attention is being drawn to a disease that continues to affect men across the Caribbean. Beyond the statistics, prostate cancer presents a growing challenge for families, healthcare providers and a region already grappling with the burden of noncommunicable diseases.
Prostate cancer is the most frequently diagnosed cancer among Caribbean men and a leading cause of cancer-related deaths.
A Caribbean concern
Research published in 2022 on prostate cancer in the Caribbean reported an age-standardized incidence rate of approximately 76 cases per 100,000 men and a mortality rate of 28 deaths per 100,000 men in 2020. These figures demonstrate the seriousness of the disease across the region, although rates vary among individual countries and territories.
The incidence figure represents new cases within a population rather than the percentage of all men who have prostate cancer. Similarly, the mortality rate reflects deaths within the population and should not be interpreted as an individual's likelihood of dying from the disease.
The Caribbean's prostate cancer burden has been linked to several factors, including an aging population, genetic risk, late diagnosis and differences in access to healthcare. Men of African ancestry are also recognized as having a higher risk of developing prostate cancer, making the issue especially relevant to predominantly Black Caribbean populations.
Prostate cancer outcomes depend heavily on the stage at diagnosis, the aggressiveness of the cancer, the man's overall health and the treatment available.
Men diagnosed with localized prostate cancer may have a strong chance of successful treatment, while advanced disease can be more difficult to treat. This difference makes early detection especially important.
Understanding the prostate
The prostate is a small gland located below the bladder that surrounds part of the urethra, the tube through which urine leaves the body. It produces fluid that forms part of semen.
As men age, the prostate may become enlarged, a condition known as benign prostatic hyperplasia, or BPH. This is not cancer, although it can cause urinary symptoms similar to those associated with prostate cancer.
Prostate cancer develops when cells in the gland grow abnormally and uncontrollably. Some cancers grow slowly, while others are more aggressive and can spread to nearby tissues, lymph nodes or distant organs, including the bones.
Who is at risk?
Age is one of the strongest risk factors for prostate cancer, with the disease becoming more common as men grow older. Family history also matters, particularly when a father or brother has been diagnosed with prostate cancer.
Other factors, including body weight, lifestyle and certain inherited genetic changes, may also influence risk. However, no single factor guarantees that a man will develop the disease.
One of the challenges of prostate cancer is that it may produce no symptoms in its early stages. A man can therefore have the disease without knowing it.
When symptoms occur, they may include difficulty starting urination, a weak urine stream, frequent urination, particularly at night, blood in the urine or semen, and pain in the back, hips or pelvis in more advanced cases.
These symptoms can also be caused by noncancerous conditions and do not automatically indicate cancer.
Screening commonly involves a prostate-specific antigen, or PSA, blood test and a digital rectal examination. The PSA test measures the level of a substance produced by the prostate, while the physical examination allows a healthcare professional to assess the gland for abnormalities.
Treatment depends on the cancer's stage and grade, as well as the patient's overall health. Options may include active surveillance, surgery, radiation therapy and hormone treatment. The outlook for men with prostate cancer is therefore not the same for everyone. Early-stage disease may be treated successfully, while advanced cancer can present more complex challenges.
The implications extend beyond individual patients. Prostate cancer places demands on public healthcare services, specialist care, diagnostic facilities and the resources required for long-term treatment. It also affects families through caregiving responsibilities, emotional stress and financial costs.
Improving awareness and access to screening discussions may help encourage earlier assessment and reduce the number of men who present with advanced disease.
Prostate Cancer Awareness Month is a reminder that men should not wait until symptoms become severe before seeking medical advice.
Knowing one's family history, understanding the risks and discussing screening with a healthcare provider are important steps. Men should also follow up on abnormal test results and seek medical attention when changes in urination or other concerning symptoms develop.
As September brings the issue into focus, the message is clear: Know the risks. Get informed. Seek medical advice. Early action matters.
